We are live on ! Find out more
PRVA icon

Privia Health

203 hedge funds and large institutions have $2.66B invested in Privia Health in 2022 Q3 according to their latest regulatory filings, with 71 funds opening new positions, 57 increasing their positions, 54 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

314% more call options, than puts

Call options by funds: $21.9M | Put options by funds: $5.28M

294% more first-time investments, than exits

New positions opened: 71 | Existing positions closed: 18

34% more funds holding

Funds holding: 151203 (+52)

31% more capital invested

Capital invested by funds: $2.03B → $2.66B (+$626M)

7.62% more ownership

Funds ownership: 64.25%71.88% (+7.6%)

6% more repeat investments, than reductions

Existing positions increased: 57 | Existing positions reduced: 54

Holders
203
Holders Change
+52
Holders Change %
+34.44%
% of All Funds
3.5%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
71
Increased
57
Reduced
54
Closed
18
Calls
$21.9M
Puts
$5.28M
Net Calls
+$16.6M
Net Calls Change
+$16.6M
Name Holding Trade Value Shares
Change
Change in
Stake
MCM
76
McKinley Capital Management
Alaska
$2.83M +$3.07M +83,110 New
California State Teachers Retirement System (CalSTRS)
77
California State Teachers Retirement System (CalSTRS)
California
$2.83M +$34.2K +925 +1%
OQS
78
Occudo Quantitative Strategies
Florida
$2.82M +$3.06M +82,751 New
Wells Fargo
79
Wells Fargo
California
$2.73M +$1.83M +49,436 +160%
AG
80
Algert Global
California
$2.71M +$2.94M +79,603 New
TD Asset Management
81
TD Asset Management
Ontario, Canada
$2.69M -$164K -4,440 -5%
SCA
82
Snowden Capital Advisors
New York
$2.69M +$2.92M +78,879 New
BA
83
Bridgewater Associates
Connecticut
$2.65M +$99.1K +2,679 +4%
Legal & General Group
84
Legal & General Group
United Kingdom
$2.63M +$2M +53,972 +233%
T. Rowe Price Associates
85
T. Rowe Price Associates
Maryland
$2.54M -$100M -2,705,766 -97%
EI
86
EAM Investors
California
$2.49M -$417K -11,287 -13%
PP
87
PDT Partners
New York
$2.45M -$1.51M -40,809 -36%
State of Wisconsin Investment Board
88
State of Wisconsin Investment Board
Wisconsin
$2.44M -$171K -4,612 -6%
CS
89
Credit Suisse
Switzerland
$2.38M +$191K +5,170 +8%
OSAM
90
O'Shaughnessy Asset Management
Connecticut
$2.34M +$2.54M +68,612 New
ECM
91
ExodusPoint Capital Management
New York
$2.23M +$1.72M +46,617 +249%
QC
92
Quadrature Capital
United Kingdom
$2.22M +$2.41M +65,205 New
Jane Street
93
Jane Street
New York
$2.01M +$815K +22,043 +60%
State of New Jersey Common Pension Fund D
94
State of New Jersey Common Pension Fund D
New Jersey
$1.96M -$1.6M -43,213 -43%
CM
95
Caption Management
Oklahoma
$1.93M -$5.29M -142,931 -72%
RhumbLine Advisers
96
RhumbLine Advisers
Massachusetts
$1.92M +$227K +6,143 +12%
Susquehanna International Group
97
Susquehanna International Group
Pennsylvania
$1.82M -$783K -21,169 -28%
AllianceBernstein
98
AllianceBernstein
Tennessee
$1.76M
Ameriprise
99
Ameriprise
Minnesota
$1.73M -$386K -10,427 -17%
DTL
100
Dynamic Technology Lab
Singapore
$1.68M +$1.82M +49,290 New

PRVA Hedge Fund Activity: Q3 2022 in Review

203 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Privia Health (PRVA) for Q3 2022, worth a combined $2.66B — up 31% from $2.03B a quarter earlier.

Buyers outnumbered sellers: 71 funds opened new PRVA positions and 18 closed out — a net gain of 53 holders — while 57 added to existing stakes and 54 trimmed.

The largest buyer was Janus Henderson Group, adding an estimated $33.4M. The largest seller was T. Rowe Price Associates, cutting an estimated $100M.

  • 203 institutional investors held Privia Health (PRVA) as of Q3 2022, up from 151 in Q2 2022.
  • Funds reported $2.66B of Privia Health stock for Q3 2022, up 31% quarter-over-quarter.
  • 71 funds opened new Privia Health positions in Q3 2022 and 18 closed out, a net change of +53 holders.
  • The largest Privia Health buyer in Q3 2022 was Janus Henderson Group, an estimated $33.4M added.
  • The largest Privia Health seller in Q3 2022 was T. Rowe Price Associates, an estimated $100M sold.

Based on aggregated 13F filings for Q3 2022.